ArticleDiscover oncology2025

A novel immune-metabolic prognostic model stratifies survival and personalizes therapy in hepatocellular carcinoma.

Zejin Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.